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Abstract.  Crossmatch tests are used for rapid identification of natural or induced anti-erythrocyte 
antibodies (hemolizines and hemaglutinines), reducing the risk of transfusion reactions. This test is 
recommended for every feline patient with unknown history and is mandatory starting with the second 
transfusion even if the blood used is of the same blood group or comes from the same donor. The 
purpose of this study is to appreciate the efficacy of some Crossmatch tests that evaluate transfusion 
compatibility in cats, by: comparing different Crossmatch tests and some anticoagulants; identifying 
donor and patient carriers of anti-erythrocyte antibodies; implementing a rapid Crossmatch test on 
slides and compatibility evaluation in cancer patients. Using one original and five known Crossmatch 
techniques on slides, pre-transfusion compatibility was tested on four sample groups of blood: 1- 
blood drawn on EDTA or CPDA1 for recipient (n=7) -donor (n=7) pre-transfusion compatibility 
evaluation; 2- blood drawn on EDTA or CPDA1 from healthy donors (n=30) and recipients (n=30); 3- 
blood samples drawn on EDTA (n=10) and CPDA1 (n=10) for evaluating their influence on 
agglutination reactions in stored blood (at 2-8
o
C for up to 15 days); 4- canine (n=5) and feline (n=5) 
blood samples to serve as “positive control reactions”. The negative Crossmatch test results in group 
one led to whole blood (WB) transfusions in all seven patients, from which we have found only one 
patient with agglutination reactions, indicating incompatibility with one of the donors. Test results 
from group two revealed a large number of agglutination reactions (eight for major and seven for 
minor Crossmatch), despite the fact that none of the subjects were previously transfused. Washing the 
red blood cells helped diminish the number of rouleaux for these patients, but without reducing the 
number of agglutinations. In group 3 we have not observed agglutination reactions after three-day 
storage in the blood samples drawn on EDTA, where as the samples drawn on CPDA1 maintained 
this capacity even after fifteen days of storage, with rouleaux formation being less frequent. The 
interspecies agglutination reactions in group four were at maximum intensity that we used as “positive 
control”. Crossmatch tests on slides proved to be as relevant as the ones performed in tubes for the 
detection of high titers of allo-antibodies, uncertain reactions needing to be clarified by adding normal 
saline and/or further examination under a microscope. Agglutinations can be attributed to group allo-
antibodies or some unknown erythrocyte antigens.  
 
Keywords: feline blood, anticoagulants, storage, compatibility, transfusion  
 
INTRODUCTION 
 
The Crossmatch test was first used in 1907 in human transfusion medicine. In the 
field of veterinary transfusion medicine, the most often used variety of this test is the 
Crossmatch in tube method that uses normal saline or antiglobulinic serum (Tocci and Ewing, 
2009). Over time many different methods of Crossmatch tests have been invented, but no 
comparative studies were made to assess their efficacy (Giger et al., 2009). 
The major Crossmatch test identifies the anti-erythrocyte antibodies against the donor’s 
red blood cells in the patient’s plasma. The minor Crossmatch detects the plasmatic antibodies 
of the donor that may bind to the patient’s erythrocytes. Agglutination or hemolysis proofs the 
existence of anti-erythrocyte antibodies and therefore the transfusion incompatibility between 
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the tested pair. A negative result in the Crossmatch test indicates transfusion compatibility of 
the tested donor-recipient pair, decreasing the chances of adverse transfusion reactions to be 
developed (Lucas et al., 2004). Feline plasma contains anti-erythrocytic aloantibodies 
(hemolysins and hemagglutinins), wich produce hemolytic and agglutination reactions in the  
Crossmatch test (Giger and Blais, 2005). The most sever adverse effects of 
transfusions are the acute hemolytic reactions (Turnwald and Pichler, 1985). The great 
clinical value of the Crossmatch test resides in its capacity to identify antibodies (Hohenhaus, 
2006). This test is able to demonstrate the existence of other potential anti-erythrocytic 
antibodies that do not belong to the AB antigenic system (Abrams-Ogg, 2000). 
 
MATERIALS AND METHODS 
  
Crossmatch tests are usually performed in medical laboratories, but the simple 
varieties that require only commonly used laboratory equipment and materials can also be 
performed in a veterinary clinic. The necessary materials are as follows: test tubes with 
EDTA and/or coagulation activators, slides and cover slips, normal saline solution, automatic 
and plastic pipettes, centrifuge (for normal sized test tubes) and micro centrifuge (for 
Eppendorf tubes), microscope, needles, syringes, thermostat, desk lamp and a stopwatch.  
Blood was drawn from donors and patients in tubes with EDTA or coagulation 
activators, and in Eppendorf microtubes that were prefilled with CPDA1. All individuals 
from the donor group fulfilled all the requisites for being accepted as potential donors.  
The patients included in this study suffered from anemic syndromes, neoplazic 
diseases or coagulopathies. We would like to mention that the majority of the females that 
took part in this study had one or multiple litters. The subjects included in this study were 
divided into 4 groups: Group 1- contained blood samples from potential donors and 
recipients (n=7) drawn onto EDTA or CPDA1 to evaluate pre-transfusion compatibility by 
performing the rapid Crossmatch test on slide; Group 2- consisted of blood samples (n=30) 
drawn from potential donors and patients tested with 3 types of Crossmatch methods; Group 
3- made up of blood samples used to evaluate the influence of refrigeration storage 
temperatures (2-8
o
C) and of some of the most commonly used anticoagulant solutions 
(EDTA and CPDA1) on the clarity and intensity of the agglutination reaction in the 
Crossmatch test. To achieve this purpose we tested samples from previously established 
partners (n=5) in successive periods (day 1 thru 5, day 10 and day 15) with the rapid 
Crossmatch method on slide;  Group 4- included canine and feline blood samples (n=5) 
drawn on EDTA crossmatched to produce a positive agglutination reaction used as reference. 
Samples from all four groups were evaluated using 3 Crossmatch methods, two of 
which performed in tubes, taken from Abrams-Ogg (2000) and Hohenhaus (2004), the third 
consisted of an original variety of Crossmatch test performed on a slide.  
Steps to perform the rapid Crossmatch test on slide are as follows:  
 Sample (0,5 ml) collection from the donor and recipient in purple top (EDTA) 
and/or red top (coagulation activator) tubes and labeling them;  
 Separation of cells from serum/plasma thru centrifugation at 3000 G for 5 
minutes, or passive sedimentation;  
 Labeling 4 slides: CM for major Crossmatch, cm for minor Crossmatch, AD for 
donor autocontrol and AP for patient autocontrol;  
 Mixing 5µl donor  red blood cells (RBCs) with 15µl recipient serum or plasma on 
the CM slide, mixing the same quantities of patient RBCs and donor serum or plasma on the 
cm slide and mixing in  the same quantities as described above, RBCs and serum or plasma 
from the same individual on AD slide for the donor and on AP slide for the patient;  
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 Reading and scoring the results according to intensity of the macroagglutinations 
(1+ =  small RBC aggregates dispersed throughout the sample; 2+ = medium sized RBC 
conglomerates; 3+ = big RBC clumps; 4+ = large, well defined RBC aggregates); 
microagglutination (microscopic RBC conglomerates) and hemolysis (reddish background) 
under microscope at 10x, 40x or even 100x, after a 3 minute reaction time;  
 Clarifying false positive results (pseudoagglutination, erythrocyte rulouxe) by 
adding 2 drops of normal saline solution to the sample and examining it under a microscope;   
 
 
RESULTS AND DISCUSSIONS 
 
In the rapid tests on slide Crossmatch test method from the first group, 6 negative 
results for both major and minor Crossmatch have been found and only one unclear result, 
represented by a medium intensity (2+)  (Tab. 1) macroagglutination was observed. The 
positive result of the autocontrol test led to the conclusion of a possible pseudoagglutination 
of the sample. Working conditions in that moment did not allow the clarification of this 
possibly false positive result thru washing and reexamination of the sample. Results found in 
this group made it possible to administer whole blood to six feline patients. Blood samples 
from this group were crossmatched immediately after collection or in the next 24 hours.  
 
Table 1 
 
Number of agglutination reactions obtained by slide Crossmatch method from the first group 
 
Crossmatch test 
 
No. agglutinations Total agglutinations 
0/+ 1+ 2+ 3+ 4+ 
Major 0 0 1* 0 0 1* 
Minor 0 0 1* 0 0 1* 
0/+ = unclear result; * Autoagglutination test was positive 2+ 
 
All samples from group 2 were tested with all three Crossmatch methods mentioned 
above. The numbers of positive results were identical in all three methods: 8 in major and 7 
in minor Crossmatch tests (Tab. 2).  
 
Table 2 
  
Agglutination reactions gained from  3 Crossmatch methods, on blood samples from the second group 
 
Crossmatch method MAJOR CROSSMATCH      Total 
+ 
MINOR CROSSMATCH    Total 
+ N 0/+ 1+ 2+ 3+ 4+ N 0/+ 1+ 2+ 3+ 4+ 
Original 30 1 0 3 1 3 8 30 1 2 2 0 2 7 
Abrams-Ogg 30 1 0 3 2 2 8 30 1 2 2 1 1 7 
Hohenhaus 30 1 0 3 1 3 8 30 1 2 2 0 2 7 
N=total number of studied samples 
 
One of each (major and minor) Crossmatch test results of maximum intensity was 
found to have a lower intensity when the method described by Abrams-Ogg’s was used, as 
compared to the rapid slide test or the Hohenhaus method was applied. Weak 
macroagglutination results were clarified with 2 drops of normal saline and reexamined 
under a microscope. In any case, a positive result of a major Crossmatch test led to the 
automatic dismissal of a transfusion between the tested donor-recipient pair. The results 
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obtained in group 3 have shown that, cold storage at 2-8
o
C on EDTA reduces in three days 
the reactivity of a feline blood sample in a Crossmatch test (Tab. 3). On the other hand, 
samples collected on CPDA1 did not demonstrate any modifications of their reactivity 
(agglutination) thru the 15 days of cold storage. Plus, we observed a drop in the occurrence 
of pseudoagglutination in the samples treated with CPDA1.  
 
Table 3 
 
Agglutination expression during storage at 2-8
o
C, obtained in Crossmatch testing 
 
Day EDTA CPDA1 
CM (n) cm (n) CM (n) cm (n) 
1 5 4 5 4 
2 5 4 5 4 
3 5 4 5 4 
4 2 1 5 4 
5 0 0 5 4 
10 - - 5 4 
15 - - 5 4 
CM (Major Crossmatch); cm (Minor Crossmatch); n= number of agglutinations 
 
The Crossmatch tests performed between the canine and feline blood samples of group 
4 displayed maximum scores of agglutination (3+ and 4+), serving very well as positive 
reference results. In the case of a maximum intensity agglutination reaction, results were 
evident in the first minute of the test. After 3 minutes results were not clear anymore due to the 
drying of the sample. Pseudoagglutinations, false positive results, due to erythrocyte rulouex 
have been found in the majority of tests, but were easily clarified with the addition of normal 
saline and reexamination under a microscope. The intensity of these reactions never exceeded a 
2+ score. Pseudoagglutinations in these cases are produced continuously until the sample has 
dried completely. In patients diagnosed with neoplazic illnesses, macroagglutinations have 
been often found alongside pseudoagglutination. None of the patients were refused from 
receiving transfusion therapies on the basis of a false negative result of the Crossmatch test.  
Results obtained in the Crossmatch test in tubes, performed with the techniques 
described by Hohenhaus and Abrams-Ogg, were clearer in the tubes incubated at 37
o
C, than 
in the ones incubated at 4
o
C, where low intensity agglutinations have been identified only 
after a microscopic examination of the sample. The aspect of a negative result was identical 
regardless of the applied technique.  Transfusions performed in patients from group 1 have 
been based on the results obtained in the Crossmatch tests, without encountering any 
complications due to potentially fatal hemolytic reactions. In the case of three patients with 
positive auto-agglutination results, additional blood typing tests have been performed to 
ensure donor-patient compatibility. RBCs from these patients had to be washed before blood 
typing by Card method, to avoid any potential false positive results. The 15 positive results 
from group 2 have been attributed to antibody detection from the AB or an unknown 
antigenic system. According to Abrams-Ogg, the Crossmatch test is less sensitive in detecting 
antibodies that cause low intensity or delayed transfusion reactions. From the Crossmatch 
techniques used in this study, the rapid method on slide proved to be the one that can be best 
applied in the working conditions found in veterinary offices and clinics from our country.  
Based upon the results gained in this study, it has become clear that further research 
regarding incompatibility reactions obtained in Crossmatch tests are needed. The Crossmatch 
test cannot replaced blood typing, but is mandatory before every transfusion therapy.  
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CONCLUSSIONS 
 
 In small animal practice, the decision to transfuse can be made based solely on the 
results of the Crossmatch tests;   
 The predominant negative results of the Crossmatch tests in cats can be correlated 
with the predominance of a single blood type in the tested feline population;  
 Positive results obtained within all Crossmatch techniques were mostly represented 
by agglutination, hemolysis was found extremely rare;  
 Agglutination reactions of variable intensity have been differentiated from false 
positive results by adding normal saline solution to the sample and reexamining it under a 
microscope;  
 Negative major/minor Crossmatch test results were attributed to the existence of 
antibodies belonging to the AB or another unknown antigenic system;  
 EDTA is not suited for a longer than 3 day storage of feline blood samples destined 
for Crossmatch tests;  
 Pseudoaggregates or erythrocyte rulouex are a frequent finding in Crossmatch test 
from feline blood samples, creating false positive results;   
 Results obtained in the rapid Crossmatch tests on slide proved that this method is as 
effective as the methods performed in tube for the detection of high titer anti-erythrocytic 
antibodies;  
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